RasGEFs (e.g., Sos1/2, RasGRF1/2, and RasGRP1‐4) primarily regulate the MAPK signaling pathway and cell proliferation/differentiation, with their mutations linked to Noonan syndrome and leukemia [7, 8, 9]. Here, SOS1 is linked to leukemia.